Characterizing the patient experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma: A qualitative study

BACKGROUND: Neoadjuvant therapy (NT) has increasingly been utilized for patients with localized pancreatic ductal adenocarcinoma (PDAC). It is the recommended approach for borderline resectable (BR) and locally advanced (LA) cancers and an increasingly utilized option for potentially resectable (PR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Lena, Brown, Zachary J, Zeh, Ryan, Monsour, Christina, Wells-Di Gregorio, Sharla, Santry, Heena, Ejaz, Aslam M, Pawlik, Timothy Michael, Cloyd, Jordan M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244990/
https://www.ncbi.nlm.nih.gov/pubmed/35949220
http://dx.doi.org/10.4251/wjgo.v14.i6.1175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244990/
https://www.ncbi.nlm.nih.gov/pubmed/35949220
http://dx.doi.org/10.4251/wjgo.v14.i6.1175

Ejemplares similares